BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 18077151)

  • 1. Gene expression predicts differential capecitabine metabolism, impacting on both pharmacokinetics and antitumour activity.
    Guichard SM; Macpherson JS; Mayer I; Reid E; Muir M; Dodds M; Alexander S; Jodrell DI
    Eur J Cancer; 2008 Jan; 44(2):310-7. PubMed ID: 18077151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive measurements of capecitabine metabolism in bladder tumors overexpressing thymidine phosphorylase by fluorine-19 magnetic resonance spectroscopy.
    Chung YL; Troy H; Judson IR; Leek R; Leach MO; Stubbs M; Harris AL; Griffiths JR
    Clin Cancer Res; 2004 Jun; 10(11):3863-70. PubMed ID: 15173095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimized blood sampling with cytidine deaminase inhibitor for improved analysis of capecitabine metabolites.
    Besnard T; Renée N; Etienne-Grimaldi MC; François E; Milano G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(1):117-20. PubMed ID: 18562256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Hollow Fibre Assay as a model for in vivo pharmacodynamics of fluoropyrimidines in colon cancer cells.
    Temmink OH; Prins HJ; van Gelderop E; Peters GJ
    Br J Cancer; 2007 Jan; 96(1):61-6. PubMed ID: 17179993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diurnal Changes in Capecitabine Clock-Controlled Metabolism Enzymes Are Responsible for Its Pharmacokinetics in Male Mice.
    Akyel YK; Ozturk Civelek D; Ozturk Seyhan N; Gul S; Gazioglu I; Pala Kara Z; Lévi F; Kavakli IH; Okyar A
    J Biol Rhythms; 2023 Apr; 38(2):171-184. PubMed ID: 36762608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between chemosensitivity and mRNA expression level of 5-fluorouracil-related metabolic enzymes during liver metastasis of colorectal cancer.
    Okumura K; Shiomi H; Mekata E; Kaizuka M; Endo Y; Kurumi Y; Tani T
    Oncol Rep; 2006 Apr; 15(4):875-82. PubMed ID: 16525674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative 19F MR spectroscopy at 3 T to detect heterogeneous capecitabine metabolism in human liver.
    Klomp D; van Laarhoven H; Scheenen T; Kamm Y; Heerschap A
    NMR Biomed; 2007 Aug; 20(5):485-92. PubMed ID: 17131325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacokinetics of capecitabine.
    Reigner B; Blesch K; Weidekamm E
    Clin Pharmacokinet; 2001; 40(2):85-104. PubMed ID: 11286326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uridine phosphorylase (-/-) murine embryonic stem cells clarify the key role of this enzyme in the regulation of the pyrimidine salvage pathway and in the activation of fluoropyrimidines.
    Cao D; Russell RL; Zhang D; Leffert JJ; Pizzorno G
    Cancer Res; 2002 Apr; 62(8):2313-7. PubMed ID: 11956089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-metastatic effect of capecitabine on human colon cancer xenografts in nude mouse rectum.
    Ninomiya I; Terada I; Yoshizumi T; Takino T; Nagai N; Morita A; Fushida S; Nishimura G; Fujimura T; Ohta T; Miwa K
    Int J Cancer; 2004 Oct; 112(1):135-42. PubMed ID: 15305385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forced expression of cytidine deaminase confers sensitivity to capecitabine.
    Morita T; Matsuzaki A; Kurokawa S; Tokue A
    Oncology; 2003; 65(3):267-74. PubMed ID: 14657601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma disposition of capecitabine and its metabolites 5'DFCR and 5'DFUR in a standard and dose-intensified monotherapy regimen.
    Czejka M; Schueller J; Farkouh A; Gruenberger B; Scheithauer W
    Cancer Chemother Pharmacol; 2011 Mar; 67(3):613-9. PubMed ID: 20495919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The predictive and therapeutic value of thymidine phosphorylase and dihydropyrimidine dehydrogenase in capecitabine (Xeloda)-based chemotherapy for head and neck cancer.
    Saito K; Khan K; Yu SZ; Ronson S; Rhee J; Li G; Van Echo D; Suntharalingam M; O'Malley BW; Li D
    Laryngoscope; 2009 Jan; 119(1):82-8. PubMed ID: 19117293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of uridine phosphorylase in tumors contributes to an improved fluoropyrimidine therapeutic activity.
    Cao D; Ziemba A; McCabe J; Yan R; Wan L; Kim B; Gach M; Flynn S; Pizzorno G
    Mol Cancer Ther; 2011 Dec; 10(12):2330-9. PubMed ID: 21954436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of 5-FU disposition after oral administration of capecitabine, a triple-prodrug of 5-FU, using a physiologically based pharmacokinetic model in a human cancer xenograft model: comparison of the simulated 5-FU exposures in the tumour tissue between human and xenograft model.
    Tsukamoto Y; Kato Y; Ura M; Horii I; Ishikawa T; Ishitsuka H; Sugiyama Y
    Biopharm Drug Dispos; 2001 Jan; 22(1):1-14. PubMed ID: 11745902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostication of pancreatic adenocarcinoma by expression of thymidine phosphorylase/dihydropyrimidine dehydrogenase ratio and its correlation with survival.
    Saif MW; Hashmi S; Bell D; Diasio RB
    Expert Opin Drug Saf; 2009 Sep; 8(5):507-14. PubMed ID: 19663627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of sensitivity to capecitabine in human renal carcinoma cells transfected with thymidine phosphorylase cDNA.
    Morita T; Matsuzaki A; Tokue A
    Int J Cancer; 2001 May; 92(3):451-6. PubMed ID: 11291085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity and substrate specificity of pyrimidine phosphorylases and their role in fluoropyrimidine sensitivity in colon cancer cell lines.
    Temmink OH; de Bruin M; Turksma AW; Cricca S; Laan AC; Peters GJ
    Int J Biochem Cell Biol; 2007; 39(3):565-75. PubMed ID: 17098463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capecitabine inhibits postoperative recurrence and metastasis after liver cancer resection in nude mice with relation to the expression of platelet-derived endothelial cell growth factor.
    Zhou J; Tang ZY; Fan J; Wu ZQ; Ji Y; Xiao YS; Shi YH; Li XM; Sun QM; Liu YK; Ye SL
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):6030-7. PubMed ID: 14676129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity of human, murine, and rat cells to 5-fluorouracil and 5'-deoxy-5-fluorouridine in relation to drug-metabolizing enzymes.
    Peters GJ; Laurensse E; Leyva A; Lankelma J; Pinedo HM
    Cancer Res; 1986 Jan; 46(1):20-8. PubMed ID: 2415245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.